|
|
||||||||
-blocking agents1. Vascular responses and noradrenaline overflows have been studied in the isolated blood-perfused cat spleen in response to electrical stimulation of the splenic nerve with trains of 200 supramaximal pulses at a frequency of 10 Hz given at 10 min intervals.
2. In the absence of blocking agents the spleen gave well-defined responses and a mean maximum overflow of 436 ± 96 pg noradrenaline per stimulus (n = 4) at the third train of stimuli.
3. Cocaine (2 x 10-5 M) increased the response nearly threefold and raised the overflow to 840 ± 131 pg/stim (n = 4). At later stimulations the responses remained stable, but the overflows rose progressively to 1076 ± 51 pg/stim after five trains of stimuli.
4. Normetanephrine (10-4 M) had no significant effect on response, but elevated the overflow to a mean maximum of 868 ± 169 pg/stim (n = 4).
5. Cocaine (2 x 10-5 M) and normetanephrine (10-4 M) given together increased the response by a factor of 6·5 and raised the overflow to 1258 ± 247 pg/stim (n = 4).
6. Hydergine (approx. 10-5 M) almost completely abolished the response and raised the overflow to 859 ± 173 pg/stim (n = 4).
7. Cocaine (2 x 10-5 M), normetanephrine (10-4 M) and hydergine (approx. 10-5 M) given in combination abolished the response and raised the overflow to 4089 ± 1148 pg/stim (n = 4).
8. Phenoxybenzamine (10-4 M) abolished the response and elevated the overflow to 4215 ± 738 pg/stim (n = 4).
9. These results are interpreted in terms of selective and combined block of `uptake I', `uptake II' and
-adrenergic receptors. Facilitation of transmitter release by
-blocking drugs, and the possible existence of an uptake process associated with the
-receptors are discussed.
This article has been cited by other articles:
![]() |
M. J. Kaufman, A. J. Siegel, J. H. Mendelson, S. L. Rose, T. J. Kukes, M. B. Sholar, S. E. Lukas, and P. F. Renshaw Cocaine administration induces human splenic constriction and altered hematologic parameters J Appl Physiol, November 1, 1998; 85(5): 1877 - 1883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |